Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.3B | 4.4B | 4.1B | 3.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 553M | 65M | 270M | 271M |
| Other operating expenses | 254M | 264M | 253M | 260M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.2B | 2.1B | 2.3B | 1.8B |
| Tax provision | 507M | 441M | 481M | 380M |
| Net income | 1.7B | 1.6B | 1.8B | 1.4B |
| Basic EPS | — | — | 7.0 | 5.4 |
| Diluted EPS | — | — | 7.0 | 5.4 |
| Basic average shares | — | — | 262.6M | 262.5M |
| Diluted average shares | — | — | 262.6M | 262.5M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.2B | 2.1B | 2.3B | 1.8B |
| Minority interests | -1M | 0 | -1M | -1M |
| Preferred stock dividends | — | — | — | — |